Chatterjee S - Search Results

1

Peptide therapeutics in the management of metastatic cancers.

Bose D, Roy L, Chatterjee S. Bose D, et al. Among authors: chatterjee s. RSC Adv. 2022 Aug 2;12(33):21353-21373. doi: 10.1039/d2ra02062a. eCollection 2022 Jul 21. RSC Adv. 2022. PMID: 35975072 Free PMC article. Review.

2

The Molecular Tête-à-Tête between G-Quadruplexes and the i-motif in the Human Genome.

Sengupta P, Bose D, Chatterjee S. Sengupta P, et al. Among authors: chatterjee s. Chembiochem. 2021 May 4;22(9):1517-1537. doi: 10.1002/cbic.202000703. Epub 2021 Feb 5. Chembiochem. 2021. PMID: 33355980 Review.

3

Targeting Ca²⁺ signaling: A new arsenal against cancer.

Panda S, Chatterjee O, Roy L, Chatterjee S. Panda S, et al. Among authors: chatterjee s, chatterjee o. Drug Discov Today. 2022 Mar;27(3):923-934. doi: 10.1016/j.drudis.2021.11.012. Epub 2021 Nov 15. Drug Discov Today. 2022. PMID: 34793973 Review.

4

Immune response and possible therapeutics in COVID-19.

Dutta A, Roy A, Roy L, Chattopadhyay S, Chatterjee S. Dutta A, et al. Among authors: chatterjee s. RSC Adv. 2021 Jan 4;11(2):960-977. doi: 10.1039/d0ra08901j. eCollection 2020 Dec 24. RSC Adv. 2021. PMID: 35423713 Free PMC article. Review.

5

De Novo designed 13 mer hairpin-peptide arrests insulin and inhibits its aggregation: role of OH-π interactions between water and hydrophobic amino acids.

Mukherjee M, Banerjee N, Chatterjee S. Mukherjee M, et al. Among authors: chatterjee s. RSC Adv. 2020 Apr 16;10(25):14991-14999. doi: 10.1039/d0ra00832j. eCollection 2020 Apr 8. RSC Adv. 2020. PMID: 35497136 Free PMC article.

6

Identification and characterization of a flexile G-quadruplex in the distal promoter region of stemness gene REX1.

Roy A, Basu D, Bose D, Dutta A, Dastidar SG, Chatterjee S. Roy A, et al. Among authors: chatterjee s. Int J Biol Macromol. 2023 Mar 15;231:123263. doi: 10.1016/j.ijbiomac.2023.123263. Epub 2023 Jan 14. Int J Biol Macromol. 2023. PMID: 36649868

7

Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics.

Roy L, Chatterjee O, Bose D, Roy A, Chatterjee S. Roy L, et al. Among authors: chatterjee s, chatterjee o. Drug Discov Today. 2023 Sep;28(9):103690. doi: 10.1016/j.drudis.2023.103690. Epub 2023 Jun 26. Drug Discov Today. 2023. PMID: 37379906 Review.

8

Unraveling the structural aspects of the G-quadruplex in SMO promoter and elucidating its contribution in transcriptional regulation.

Roy L, Roy A, Bose D, Banerjee N, Chatterjee S. Roy L, et al. Among authors: chatterjee s. J Biomol Struct Dyn. 2023 Oct 25:1-16. doi: 10.1080/07391102.2023.2268200. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37878583

9

Switchable tetraplex elements in the heterogeneous nuclear ribonucleoprotein K promoter: micro-environment dictated structural transitions of G/C rich elements.

Bose D, Banerjee N, Roy A, Sengupta P, Chatterjee S. Bose D, et al. Among authors: chatterjee s. J Biomol Struct Dyn. 2024 Jan 18:1-18. doi: 10.1080/07391102.2024.2303378. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38235706

10

Frontiers in G-Quadruplex therapeutics in cancer: Selection of small molecules, peptides and aptamers.

Banerjee N, Panda S, Chatterjee S. Banerjee N, et al. Among authors: chatterjee s. Chem Biol Drug Des. 2022 Jan;99(1):1-31. doi: 10.1111/cbdd.13910. Epub 2021 Sep 26. Chem Biol Drug Des. 2022. PMID: 34148284 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,768 results

Search Page